IIL to produce drug substance for Covaxin - The Hindu BusinessLine

IIL to produce drug substance for Covaxin
May 28, 2021
IIL is expected to produce the drug for about 10-15 million doses per month
Indian Immunologicals Ltd (IIL) is planning to start the production of drug substance for Bharat Biotech’s Covaxin, from June 15.
The first batch of the drug will be sent to Bharat Biotech by July, K Anand Kumar, Managing Director, IIL, said in a release issued here on Friday.
IIL is expected to produce the drug for about 10-15 million doses per month. Initially, it will produce for 2-3 million doses and it will be scaled up to 6-7 million per month later in the year, Kumar said.

Related Keywords

India ,Hyderabad ,Andhra Pradesh ,Atmanirbhar Bharat ,Rk Anand Kumar ,Indian Immunologicals Ltd ,Mission Covid Suraksha ,Department Of Biotechnology ,Bharat Biotech ,Managing Director ,Covid Suraksha ,Indigenous Covid ,Tiil ,Covaxin ,Covid 19 ,Vaccine ,Aatmanirbar Bharat ,Bharat Biotechs Covaxin ,இந்தியா ,ஹைதராபாத் ,ஆந்திரா பிரதேஷ் ,கே ஆனந்த் குமார் ,துறை ஆஃப் உயிரி தொழில்நுட்பவியல் ,பாரத் பயோடெக் ,நிர்வகித்தல் இயக்குனர் ,தடுப்பூசி ,